Catalyst Pharmaceuticals, Inc. (CPRX)
CIK 1369568 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Catalyst Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jul 24, 2026 | 15-12G | 0001193125-26-315836 |
| Jul 17, 2026 | 4 | 0001161697-26-000183 |
| Jul 17, 2026 | 4 | 0001161697-26-000177 |
| Jul 17, 2026 | 4 | 0001161697-26-000181 |
| Jul 17, 2026 | 4 | 0001161697-26-000178 |
| Jul 17, 2026 | 4 | 0001161697-26-000173 |
| Jul 17, 2026 | 4 | 0001161697-26-000182 |
| Jul 17, 2026 | 4 | 0001161697-26-000174 |
| Jul 17, 2026 | 4 | 0001161697-26-000176 |
| Jul 17, 2026 | 4 | 0001161697-26-000184 |
| Jul 17, 2026 | 4 | 0001161697-26-000172 |
| Jul 17, 2026 | 4 | 0001161697-26-000171 |
| Jul 17, 2026 | 4 | 0001161697-26-000175 |
| Jul 17, 2026 | 4 | 0001161697-26-000179 |
| Jul 17, 2026 | 4 | 0001161697-26-000180 |
| Jul 16, 2026 | EFFECT | 9999999995-26-002324 |
| Jul 16, 2026 | POS AM | 0001193125-26-305099 |
| Jul 16, 2026 | S-8 POS | 0001193125-26-305114 |
| Jul 16, 2026 | POSASR | 0001193125-26-305106 |
| Jul 16, 2026 | EFFECT | 9999999995-26-002322 |
| Jul 16, 2026 | POS AM | 0001193125-26-305097 |
| Jul 16, 2026 | 8-K | 0001193125-26-304984 |
| Jul 16, 2026 | EFFECT | 9999999995-26-002323 |
| Jul 16, 2026 | S-8 POS | 0001193125-26-305107 |
| Jul 16, 2026 | S-8 POS | 0001193125-26-305120 |